4 medicines held by Bristol-Myers Squibb/Pfizer EEIG on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Eliquis 0.15 mg granules in capsules for opening EU/1/11/691/016 |
Apixaban | Bristol-Myers Squibb/Pfizer EEIG | — |
| Eliquis 0.5 mg coated granule in sachet EU/1/11/691/017 |
Apixaban | Bristol-Myers Squibb/Pfizer EEIG | — |
| Eliquis 1.5 mg coated granule in sachet EU/1/11/691/018 |
Apixaban | Bristol-Myers Squibb/Pfizer EEIG | — |
| Eliquis 2 mg coated granule in sachet EU/1/11/691/019 |
Apixaban | Bristol-Myers Squibb/Pfizer EEIG | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.